Keywords: new, data, published, dor, orbec, biopharma, late-stage

New data published on DOR's orBec

Article | 22 September 2008

DOR BioPharma, a US late-stage biopharmaceutical company developing products to treat side effects of cancer treatments and serious gastrointestinal diseases, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing